Exercise Training Intervention in Children With Type 1 Diabetes
- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- Behavioral: Exercise training program
- Registration Number
- NCT01220479
- Lead Sponsor
- University Hospital, Geneva
- Brief Summary
Type 1 diabetes mellitus (T1DM) is associated with multiple co-morbidities, such as hypertension, dyslipidemia, coronary heart disease and osteoporosis. The foundation of these conditions lays in childhood. Exercise is known to have a positive influence on bone mineral density (BMD) and some impact on cardiovascular disease risk factors in healthy children, but little is known about these associations in children with T1DM.
The main purpose of this study is to assess the effects of a 9-month weight-bearing exercise training program on skeletal development in children with T1DM, compared to healthy subjects. The second aim is to evaluate whether the program influences also cardiovascular diseases risk factors.
This is a randomized controlled study incorporating 30 children with T1DM and 30 healthy children. Both groups are randomly divided (1:1) in an exercise or a control group: 1) exercise diabetic, 2) controls diabetic, 3) exercise healthy, 4) controls healthy.
Exercise groups participate to an identical weight-bearing exercise training program 2 x 90 minutes per week and controls are relatively inactive.
Main measures include: total body, lumbar spine and hip BMD by DXA, body fat and fat-free mass, bone biomarkers levels, resting and ambulatory blood pressure and fasting blood lipids.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 59
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Control Healthy Exercise training program - Control Diabetic Exercise training program - Exercise Diabetic Exercise training program - Exercise Healthy Exercise training program -
- Primary Outcome Measures
Name Time Method Bone mineral density and content at 9 months Assessment of bone mineral density (BMD) and content (BMC) at the whole body, hip and lumbar spine using DXA.
- Secondary Outcome Measures
Name Time Method Anthropometrics at 9 months Body weight, height, body mass index and pubertal stage
Blood lipids levels at 9 months Fasting total cholesterol, LDL-Cholesterol, HDL-Cholesterol, triglycerides, lipoprotein (a), apolipoproteins A-I and B levels.
Physical activity at 9 months Physical activity level by questionnaire and accelerometer
Nutrition at 9 months Total energy, proteins, lipids, carbohydrates and calcium intakes using food records
Circulating bone biomarkers levels at 9 months Serum levels of beta-CrossLaps (CTX), N-MID-Osteocalcin (OC), N-Terminal Propeptide of Type I Collagen (PINP) and 25-OH-vitamin D (25-OH-D)
Glycated Haemoglobin at 9 months capillary HbA1c levels
Systemic blood pressure at 9 months Resting and 24-hour ambulatory systemic blood pressure monitoring
Body composition at 9 months Assessment of whole body and abdominal fat mass, and total fat-free mass using DXA.
Trial Locations
- Locations (1)
University Hospital of Geneva
🇨🇭Geneva, Switzerland